Sonja Nelson

Sonja Nelson

Director of Finance/CFO at
Ambrx Biopharma, Inc.
53 year
Health Technology
Consumer Services
Communications

Profile

Sonja Nelson is currently Chief Financial Officer at Ambrx, Inc. since 2021 and Chief Financial Officer at Ambrx Biopharma Cayman, Inc. since 2023.
Former positions include Independent Director at Motus GI Holdings, Inc. from 2021 to 2024, Director at Inex Bio, Inc. from 2017 to 2021, Chief Financial Officer at NantKwest, Inc. from 2018 to 2021, Senior Vice President-Finance at ImmunityBio, Inc. in 2021, Vice President & Controller at AltheaDx, Inc. from 2014 to 2015, Senior Director & Controller at Mallinckrodt Hospital Products, Inc. from 2012 to 2014, Director-General Accounting at Cricket Communications, Inc. from 2008 to 2012, and Vice President-Research & Development at NEON Enterprise Software LLC.
Education includes undergraduate studies at Agnes Scott College and the University of Pforzheim.

Sonja Nelson active positions

CompaniesPositionStart
Director of Finance/CFO 30/06/2021

Former positions of Sonja Nelson

CompaniesPositionEnd
MOTUS GI HOLDINGS, INC. Director/Board Member 31/07/2024
IMMUNITYBIO, INC. Corporate Officer/Principal 01/06/2021
Director/Board Member 01/06/2021
IMMUNITYBIO, INC. Director of Finance/CFO 09/03/2021
ALTHEADX INC Comptroller/Controller/Auditor 01/10/2015
See the detail of Sonja Nelson's experience

Education of Sonja Nelson

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

52

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Communications

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Technology Services

Consumer Services

Finance

Health Technology

Health Technology

Health Technology